HOME >> BIOLOGY >> NEWS
UC Riverside biochemists develop technology to increase Vitamin C in plants

RIVERSIDE, Calif. -- March 5, 2003 -- Biochemist Daniel R. Gallie at the University of California, Riverside and his research team of Zhong Chen, Todd Young, Jun Ling, and Su-Chih Chang report in the March 18, 2003, issue of the Proceedings of the National Academy of Sciences (PNAS) that they have developed technology that increases the amount of vitamin C in plants, including grains, by increasing the amount of the enzyme that is responsible for recycling vitamin C. "The ability to increase the level of vitamin C in plant food will enhance their nutritive value," said Gallie, who is professor of biochemistry. The research was funded by the U.S. Department of Agriculture and the University of California Agricultural Experiment Station over the last 5 years.

Vitamin C, or ascorbic acid, is essential to prevent diseases, such as scurvy, that affect the connective tissue. It also improves cardiovascular and immune cell function and is used to regenerate vitamin E. In contrast to most animals, humans cannot make vitamin C and it must, therefore, be obtained regularly from dietary sources. Vitamin C is present at high levels in some fruits such as citrus and some green leafy vegetables, but present in low levels in those crops most important to humans such as grains.

"Once used, vitamin C can be regenerated by the enzyme dehydroascorbate reductase or DHAR," explained Gallie. "Through this means, plants recycle the vitamin so that it can be used repeatedly. If vitamin C is not salvaged by DHAR, it is quickly lost."

In the PNAS paper, the authors reason that increasing the amount of DHAR in plants might improve their ability to recycle vitamin C and thereby increase its amount. To examine this, the researchers introduced the gene encoding DHAR from wheat into corn to increase the amount of DHAR by up to 100-fold.

"We found that the increase in DHAR elevated the amount of vitamin C in grain and leaves of corn, showing that th
'"/>

Contact: Iqbal Pittalwala
iqbal@citrus.ucr.edu
909-787-2645
University of California - Riverside
5-Mar-2003


Page: 1 2 3

Related biology news :

1. Humans march to a faster genetic drummer than primates, UC Riverside research says
2. UC Riverside researcher takes snapshots of the movement of molecules in a billionth of a second
3. UC Riverside researchers discover new way to identify cell growth
4. UC Riverside professor to spend year with US State Department
5. UC Riverside researchers develop low-carb corn with enhanced protein and oil
6. UC Riverside researchers improve drought tolerance in plants
7. Plant sex protein identified at UC Riverside
8. UC Riverside researchers publish paper on botulism detection system
9. UC Riverside to convene conference on genetically modified organisms, Oct. 14-17, 2003
10. UC Riverside plant pathologist awarded $1 million grant to study virus assembly
11. UC Riverside study indicates mosquito coils may cause cancer

Post Your Comments:
(Date:5/21/2013)... MA -- Over the past few decades, scientists have ... angioplasty balloons and metallic stents. While generally effective, each ... side effects. , A new study from MIT analyzes ... the benefits of angioplasty balloons and drug-releasing stents, but ... balloon is inflated in the artery for only a ...
(Date:5/20/2013)... are also commonly resistant to antimicrobial substances made ... in mBio , the online open-access journal ... colistin and host antimicrobials LL-37 and lysozyme, which ... mean that patients with life-threatening multi-drug resistant infections ... Colistin is a last-line drug for treating several ...
(Date:5/20/2013)... (NSF) planning grant will help establish the Center for ... the University of Illinois at Urbana-Champaign and Worcester Polytechnic ... devoted to research in drying moist, porous materials such ... products; chemical products; textiles; and biopharmaceuticals," said Hao Feng, ... human nutrition and the Illinois site director. , According ...
Breaking Biology News(10 mins):Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3NSF approves planning grant for Center for Advanced Research in Drying 2
(Date:5/21/2013)... MN (PRWEB) May 21, 2013 The ... show display solution for sales and marketing teams looking for ... describes the kit as “everything you’ll need to put ... Fabric Display Kit comes with a number of displays and ... trade booth 20 feet by 20 feet in size. These ...
(Date:5/20/2013)... May 21, 2013 Grace Century ... in “game-changing” life science and health related private equity ... to its International Project Team. Dergham's expertise in finance ... multi-cultural depth to Grace Century as it continues to ... , Ms. Dergham holds both an under graduate degree ...
(Date:5/20/2013)... , May 20, 2013 Today, at the ... Francisco , James McGough , ... at the Semel Institute for Neuroscience and Human Behavior ... Medicine at the University of California Los Angeles (UCLA), ... and Adolescent Psychopharmacology and ADHD at UCLA, presented the ...
(Date:5/20/2013)... , May 20, 2013 Pacific Biomarkers and Clinigene ... for developers of biosimilars at the 2013 AAPS/ ... San Diego Hotel and Marina , ... have the opportunity to speak with company representatives at ... That Cross" on May 21 from 1-2 p.m. in ...
Breaking Biology Technology:GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 2Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 3Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 4Positive Results Reported for Phase I Clinical Trial at UCLA for the Treatment of ADHD in Children Using External Trigeminal Nerve Stimulation (eTNS) 5Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference 2
Cached News: